Innovacell

Developer of autologous cell therapies for the treatment of incontinence-related indications

placeShinagawa, Tokyo, Japan calendar_todayFounded 2021 groups20 employees language innovacell.co.jp

Innovation

4 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 251 times.

YearFilings
20231
20242
20254
20262

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon